CH297285A - Process for preparing 2,4-diamino-5-paranitrobenzyl-6-methyl-pyrimidine. - Google Patents

Process for preparing 2,4-diamino-5-paranitrobenzyl-6-methyl-pyrimidine.

Info

Publication number
CH297285A
CH297285A CH297285DA CH297285A CH 297285 A CH297285 A CH 297285A CH 297285D A CH297285D A CH 297285DA CH 297285 A CH297285 A CH 297285A
Authority
CH
Switzerland
Prior art keywords
diamino
pyrimidine
methyl
paranitrobenzyl
preparing
Prior art date
Application number
Other languages
French (fr)
Inventor
Limited The Wellcom Foundation
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH297285A publication Critical patent/CH297285A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  

  Procédé de préparation de la     2,4-dianiino-5-paranitrobenzyl-6-méthyl-pyrimidine.       On donne au brevet,     No   <B>294175</B> des     indi-          eations    concernant l'activité     combattive    de la  malaria de nouvelles     5-benzyl-2,4-diamino-          p#-rimidines    de formule:  
EMI0001.0008     
    dans laquelle X représente un atome de chlore,  de brome ou un groupe     nitro    et R un atome  d'hydrogène ou un groupe méthyle.  



  Ce brevet principal porte sur un procédé  de préparation de l'une de ces nouvelles       pyrimidines,   <B>à</B> savoir la     2,4-diamino-5-para-          chlorobenzyl-6-méthyl-pyrimidine.     



  Le présent brevet additionnel a pour objet  un procédé de préparation de la     2,4-diamino-          5-paranitrobenzyl-6-métliyl        -pyrimidine,    nou  veau composé possédant également une acti  vité     eombattive    de la malaria le rendant uti  lisable en thérapeutique.  



  Ce procédé est caractérisé en ce que l'on  condense de la     guanidine    avec un composé de  formule:  
EMI0001.0018     
    dans laquelle     R'    représente un groupe alcoyle  inférieur, puis en ce que l'on transforme la       2-amino-4-hydroxy-5-paranitrobenzyl-6-méthyl-          pyrimidine    obtenue en la     2,4-diaminopyrimi-          dine    correspondante, par halogénation et     ami-          nation.     



  Voici,<B>à</B> titre d'exemple, comment le pro  <B>cédé</B> de l'invention peut être réalisé en pra  tique:  On prépare l'ester de départ,<B>à</B> savoir le       p-nitrobenzylacétoacétate    d'éthyle,<B>à</B> partir de  .bromure de     p-nitrobenzyle,    d'hydroxyde de  sodium et     d'acétoacéta-te    d'éthyle dans de  l'alcool<B>à</B> 90%, selon la méthode de     Burgess,          ,T.        Chem.    Soc.<B>2017 (A 27).</B> On obtient avec  <B>65</B> % de rendement un produit brut qui fond  <B>à</B>     40-430    (selon la bibliographie 43--450).  



  Le     p-nitrobenzylacétoacétate    d'éthyle brut  ainsi obtenu est condensé avec de la     guanidine.     Dans ce but, on<B>le</B> dissout dans<B>1</B> litre     dalcool     absolu auquel on ajoute 22<B>g</B> de carbonate de       guanidine    et le mélange est chauffé au reflux  pendant<B>5</B> heures. Le mélange réactionnel est  versé dans 2 litres d'eau, neutralisé avec de  l'acide acétique et la     2-a-mino-4-hydroxy-5-p-          nitrobenzyl-6-méthylpyr        imidine    est obtenue  par filtration.  



  Après précipitation de ce dernier composé,  on le chauffe au reflux avec de     l'oxyehlorure     de phosphore<B>(100</B>     em3)    pendant<B>30</B> minutes.  Après évacuation de l'excès de chlorure de       phosphoryle    par distillation dans le vide, le      résidu est versé sur de, la, glace et le mélange  est rendu légèrement alcalin<B>à</B> l'aide d'ammo  niaque.

   La     2-amino-4-ehloropyrimidine    est sé  parée par filtration, transférée dans une  bombe et chauffée<B>à 155-1600</B> pendant  <B>16</B> heures avec<B>100</B>     ems    d'une solution     alcooli-          que    qui a été saturée de gaz ammoniac entre  <B>0</B> et     511.    Le contenu de la bombe est évaporé  <B>à</B> sec et le résidu solide est lavé avec<B>25</B>     em3     d'une solution<B>2N</B> d'hydroxyde de sodium. Le  solide     obtena    est purifié par dissolution dans  de l'acide chlorhydrique dilué et précipi  tation<B>à</B> l'aide d'hydroxyde de sodium.

   Après  deux recristallisations, comme indiqué ci-des  sus, on obtient la     2,4-diamino-5-paraliitro-          benzyl-6-méthyl-pyi,imidine    sous forme de  cristaux fondant<B>à</B> 240-2420<B>C.</B>



  Process for preparing 2,4-dianiino-5-paranitrobenzyl-6-methyl-pyrimidine. New 5-benzyl-2,4-diamino- p # -rimidines of the formula are given in Patent No. <B> 294175 </B> concerning the fighting activity of malaria:
EMI0001.0008
    in which X represents a chlorine atom, a bromine atom or a nitro group and R a hydrogen atom or a methyl group.



  This main patent relates to a process for preparing one of these novel pyrimidines, <B> namely </B> 2,4-diamino-5-para-chlorobenzyl-6-methyl-pyrimidine.



  The subject of the present additional patent is a process for the preparation of 2,4-diamino-5-paranitrobenzyl-6-methyl-pyrimidine, a new compound also possessing a combating activity against malaria, making it useful in therapy.



  This process is characterized in that guanidine is condensed with a compound of formula:
EMI0001.0018
    in which R 'represents a lower alkyl group, then in that the 2-amino-4-hydroxy-5-paranitrobenzyl-6-methyl-pyrimidine obtained is converted into the corresponding 2,4-diaminopyrimidine, by halogenation and amination.



  Here is, <B> to </B> by way of example, how the <B> assigned </B> process of the invention can be carried out in practice: The starting ester is prepared, <B> to < / B> namely ethyl p-nitrobenzylacetoacetate, <B> to </B> from p-nitrobenzyl bromide, sodium hydroxide and ethyl acetoaceta-te in alcohol <B > at </B> 90%, according to the Burgess method,, T. Chem. Soc. <B> 2017 (A 27). </B> With <B> 65 </B>% yield, a crude product is obtained which melts <B> at </B> 40-430 (according to bibliography 43 --450).



  The crude ethyl p-nitrobenzylacetoacetate thus obtained is condensed with guanidine. For this purpose, it is <B> </B> dissolved in <B> 1 </B> liter of absolute alcohol to which is added 22 <B> g </B> of guanidine carbonate and the mixture is heated under reflux for <B> 5 </B> hours. The reaction mixture is poured into 2 liters of water, neutralized with acetic acid and 2-a-mino-4-hydroxy-5-p-nitrobenzyl-6-methylpyr imidine is obtained by filtration.



  After precipitation of the latter compound, it is heated to reflux with phosphorus oxyehloride <B> (100 </B> em3) for <B> 30 </B> minutes. After removing the excess phosphoryl chloride by vacuum distillation, the residue is poured onto ice and the mixture is made slightly alkaline <B> with </B> using ammonia.

   The 2-amino-4-ehloropyrimidine is separated by filtration, transferred to a bomb and heated <B> to 155-1600 </B> for <B> 16 </B> hours with <B> 100 </B> ems of an alcoholic solution which has been saturated with ammonia gas between <B> 0 </B> and 511. The contents of the bomb are evaporated <B> to </B> to dryness and the solid residue is washed with <B> 25 </B> em3 of a <B> 2N </B> solution of sodium hydroxide. The solid obtained is purified by dissolving in dilute hydrochloric acid and precipitating <B> with </B> the aid of sodium hydroxide.

   After two recrystallizations, as indicated above, 2,4-diamino-5-paraliitro-benzyl-6-methyl-pyi, imidine is obtained in the form of crystals melting <B> at </B> 240-2420 < B> C. </B>

 

Claims (1)

REVENDICATION<B>-</B> Procédé de préparation<B>de,</B> la 2,4-diamino- 5-paranitroben7yl-6-mét,hyl-pyrimidine, carac- térisé en ce que lon cond.... de la guanidine avec un composé de formule: CLAIM <B> - </B> Process for the preparation <B> of, </B> 2,4-diamino-5-paranitroben7yl-6-met, hyl-pyrimidine, characterized in that the cond .. .. guanidine with a compound of formula: EMI0002.0016 dam laquelle R' représente un groupe alcoyle inférieur, puis en ce que l'on transforme la 2-amino-4-hydroxy-5-paranitrobenz.vl-6-métli.vl- pyrimidine obtenue en la 2,4-diamino-p.#-rimi- dine correspondante, par halogénation et ami- nation. Cette dernière p.vrimidine se présente sous forme de cristaux fondant<B>à</B> 2-10-2420 <B>C;</B> elle possède une activité combattive de la ma laria qui la rend utilisable en thérapeutique. EMI0002.0016 dam in which R 'represents a lower alkyl group, then in that the 2-amino-4-hydroxy-5-paranitrobenz.vl-6-métli.vl-pyrimidine obtained is converted into the 2,4-diamino-p . # - corresponding rimidine, by halogenation and amination. The latter p.vrimidine is in the form of crystals melting <B> at </B> 2-10-2420 <B> C; </B> it has a fighting activity against ma laria which makes it usable in therapy.
CH297285D 1950-09-26 1950-12-22 Process for preparing 2,4-diamino-5-paranitrobenzyl-6-methyl-pyrimidine. CH297285A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US297285XA 1950-09-26 1950-09-26
CH294175T 1950-12-22

Publications (1)

Publication Number Publication Date
CH297285A true CH297285A (en) 1954-03-15

Family

ID=25733459

Family Applications (1)

Application Number Title Priority Date Filing Date
CH297285D CH297285A (en) 1950-09-26 1950-12-22 Process for preparing 2,4-diamino-5-paranitrobenzyl-6-methyl-pyrimidine.

Country Status (1)

Country Link
CH (1) CH297285A (en)

Similar Documents

Publication Publication Date Title
MC509A1 (en) New substituted benzylsulfonamides and their preparation
EP0486385B1 (en) Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them
CH616418A5 (en)
EP0025370B1 (en) Preparation of fluorinated methylaminoalkanoic acids, process intermediates and their preparation
CH297284A (en) Process for preparing 2,4-diamino-5-parabromobenzyl-6-methyl-pyrimidine.
EP0713865B1 (en) 2-Aminobenzenesulphonic acid and 2-aminobenzenesulphonyl chloride derivatives, their preparation and their use as synthetic intermediates
CH294175A (en) Process for preparing 2,4-diamino-5-parachlorobenzyl-6-methylpyrimidine.
FR2510560A1 (en) PROCESS FOR THE PREPARATION OF 4-AMINO BUTYRAMIDE
EP3759081A1 (en) An improved process for the preparation of propiomazine maleate
Wenner 6, 7-Dihydro-5H-Dibenz [c, e] Azepine Derivatives
CH623818A5 (en) Process for producing derivatives of thiochroman
CH313556A (en) Process for the preparation of novel aminoalkyl-10-phenothiazines
FR2494584A1 (en) MEDICINES CONSISTING OF NEW 2-AMINOETHANOLS AND THEIR MANUFACTURING PROCESS
JPS6257620B2 (en)
CA1183137A (en) 3-[2-(4-piperidyl) 1-alkyl ethyl] indoles and use thereof as therapeutic agents
CH373038A (en) Process for the preparation of novel 2-piperidyl aryl methanol ethers
Steinberg et al. Aminoalkyl Esters of 1, 2, 3, 10b-Tetrahydrofluoranthene-10b-carboxylic Acid
FR2494696A1 (en) NOVEL PROCESS FOR THE PREPARATION OF 3-AMINO STEROIDS AND THEIR SALTS
EP0145591A2 (en) Pyrrolo(3,2,1-hi)indole derivatives, their preparation and their therapeutical use
SU57506A1 (en) The method of obtaining 1-phenyl-3-methyl-pyrazolone
CH237879A (en) Process for the preparation of -dimethyl-ss-cyclohexylethylamine.
BE876900A (en) PROCESS FOR THE PRODUCTION OF PYRROLIDINE-2-ONES FROM 3-PYRROLINE-2-ONES AND FOR THE PRODUCTION OF 3-PYRROLINE-2-ONES
CH311406A (en) Process for the preparation of 1-carbobenzoxy-4-carbamyl-piperazine.
CH327924A (en) Process for manufacturing substituted tetrazolines
CH345651A (en) Process for the preparation of novel amines derived from phenothiazine